trending Market Intelligence /marketintelligence/en/news-insights/trending/5WbX76Pruu78R4INtKe69w2 content esgSubNav
In This List

Catalyst Biosciences closes common stock offering

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Catalyst Biosciences closes common stock offering

Catalyst Biosciences Inc. closed its underwritten public offering of 1,105,263 common shares at $9.50 apiece with gross proceeds of about $10.5 million.

JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. acted as joint book-running managers. LifeSci Capital LLC served as a co-manager for the offering.